Project Grant R01DK149331

The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Nemours Foundation $763,505 on September 3, 2026, to conduct a rigorous multisite randomized controlled trial of TYPE 1 TOGETHER, a peer mentoring intervention designed to improve continuous glucose monitoring (CGM) wear time and glycemic control in adolescents with Type 1 Diabetes.

TYPE 1 TOGETHER combines peer mentoring from trained peer mentor families with community health worker support to address personal, behavioral, and environmental barriers to consistent CGM use. The intervention targets adolescents whose suboptimal adherence to CGM—wearing it fewer than 80 percent of the time—increases risk for acute and long-term diabetes complications. The trial will recruit 180 adolescent-caregiver dyads across three sites: Nemours Delaware (Wilmington, Delaware, the place of performance), Nemours Orlando, and University of Tennessee Memphis. Participants will be randomized 1:1 to receive TYPE 1 TOGETHER or a six-month waitlist control, with families meeting at least monthly with a peer mentor family and community health worker during the intervention phase. The award supports research activities through May 31, 2031.

This project grant is funded under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), which supports basic and clinical biomedical research improving understanding, prevention, diagnosis, and treatment of diabetes and related diseases.